|Day Low/High||31.00 / 32.87|
|52 Wk Low/High||22.83 / 35.59|
Amid this crisis, we've changed our lifestyles and habits in ways likely to stay, even after the smoke clears.
Kroger could produce strong earnings as it stands by its guidance, but uncertainty lingers, so here's how I'd play the name.
The technical signals for the producer of packaged foods are largely positive and point to litte overhead resistance for its shares.
Now that the service economy is pretty much stopped in its tracks, here are promising areas, including technology as manufacturing, to consider.
I have no false illusion about striking it rich in this name, but a staple such as this can have a place in my portfolio.
I don't think it would be too much of a stretch to imagine that too many investors, or citizens for that matter, will mind seeing March 2020 head on out of here.
Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.
I would still like to see a day where the broad indices perform well on volume that grows from the day prior, but is that because I am too experienced?
Before taking the stage at the CAGNY investor conference in Orlando, General Mills reiterated its recent guidance that calls for organic sales growth of 1%-2% this year and constant-currency adjusted diluted EPS to be up 3%-5% vs. +5% consensus. It ...
How about some potentially positive news... Casinos in Macau are set to reopen Wednesday (Feb. 19), which is expected to provide some relief to casino operators including Las Vegas Sands , MGM Resorts International , Wynn Resorts and Galaxy Enterta...
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
There are two overt threats to market health and by extension to U.S. economic growth.
This week brings key results from Micron, Nike and FedEx, among others.
Turning to corporate earnings to be had next week, much like this week there will be a handful of ones to dissect ahead of the upcoming December quarter earnings bonanza that will kick off in about one month. Here are some of the ones worth watching...
I think I can find room for this one, and I did not expect to when I started writing this piece.
Does the Fed just keep injecting liquidity into money markets every single night forever?
Post's IPO of its star Active Nutrition segment is expected to take place in the December quarter.
The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.
We have to hope they are given a better chance to tell their story than they were Wednesday.
Eclectic leadership is not the kind of leadership I can bank on.
The Fed needs to buy short-term paper RIGHT NOW, and sell off longer-term paper.
In this day and age, companies must be 'disruptors' or get left in the dust.